Celltrion Launches Autoimmune Disease Biosimilar Avtozma in U.S.
Seoul: Celltrion Inc., a leading South Korean biopharmaceutical company, announced the launch of its biosimilar Avtozma for treating autoimmune diseases in the United States. The
Seoul: Celltrion Inc., a leading South Korean biopharmaceutical company, announced the launch of its biosimilar Avtozma for treating autoimmune diseases in the United States. The
Seoul: The Ministry of Science and ICT announced on Monday that it has requested police intervention to investigate claims that KT Corp. has hindered a
Seoul: Defense Minister Ahn Gyu-back stated on Monday his belief that the U.S. Forces Korea’s (USFK) recent modernization initiatives are primarily focused on enhancing deterrence
Seoul: A Seoul court said Monday it has allowed the broadcast of surveillance camera footage allegedly showing former Prime Minister Han Duck-soo picking up martial
Daegu: The Samsung Lions secured a pivotal victory against the SSG Landers, winning 5-3 on Monday to position themselves one win away from advancing in
Seoul: A Singapore-based investment fund has sold an education-focused commercial building in southern Seoul for around 54 billion won (US$37.8 million), the investment company said
The “Korean News Digest” website serves as a comprehensive hub for news, catering to an expansive range of categories including General, Business, Science, Fashion, Medical, Games, Governance, and Press Releases.
Â
The “Korean News Digest” website serves as a comprehensive hub for news, catering to an expansive range of categories including General, Business, Science, Fashion, Medical, Games, Governance, and Press Releases.
This diverse coverage showcases the site’s commitment to broad-spectrum news dissemination, aiming to engage a diverse audience with varied interests across multiple disciplines.